PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY-COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN

被引：1
|
作者：
Quinzler, R. [1 ]
Ude, M. [2 ]
Franzmann, A. [1 ]
Feldt, S. [1 ]
Leuner, K. [2 ]
Mueller, W. E. [2 ]
Dippel, F. W. [3 ]
Schulz, M. [4 ]
机构：
[1] German Inst Drug Use Evaluat DAPI, GIDE, Eschborn, Hessen, Germany
[2] Goethe Univ Frankfurt, Frankfurt, Hessen, Germany
[3] Sanofi Aventis, Berlin, Germany
[4] ABDA Fed Union German Assoc Pharmacists, Berlin, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74141-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A234 / A234
页数：1
相关论文
共 50 条
  • [1] Higher Persistence with Basal Supported Oral Therapy (BOT) with Insulin Glargine Compared to NPH Insulin Therapy Combined with Oral Antidiabetics
    Pfohl, M.
    Dippel, F. -W.
    Kostev, K.
    Maltz, A.
    Kotowa, W.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 (03) : 166 - 171
  • [2] Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
    Quinzler, Renate
    Ude, Miriam
    Franzmann, Alexandra
    Feldt, Sandra
    Schuessell, Katrin
    Leuner, Kristina
    Mueller, Walter E.
    Dippel, Franz-Werner
    Schulz, Martin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (01) : 24 - 32
  • [3] Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin
    Rosenstock, J
    Schwartz, SL
    Clark, CM
    Park, GD
    Donley, DW
    Edwards, MB
    [J]. DIABETES CARE, 2001, 24 (04) : 631 - 636
  • [4] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [5] ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN
    Pfohl, M.
    Dippel, F. W.
    Kostev, K.
    Kotowa, W.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A509 - A510
  • [6] Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy:: Comparison of insulin glargine with NPH insulin as basal insulin supplement
    Ploeckinger, Ursula
    Topuz, Mendaha
    Riese, Brigitte
    Reuter, Thomas
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 290 - 295
  • [7] Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control
    Starkman, Harold
    Frydman, Emily
    Bustami, Rami
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (5-6): : 369 - 371
  • [8] Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
    Stuermer, Til
    Marquis, M. Alison
    Zhou, Haibo
    Meigs, James B.
    Lim, Soo
    Blonde, Lawrence
    MacDonald, Eileen
    Wang, Ray
    LaVange, Lisa M.
    Pate, Virginia
    Buse, John B.
    [J]. DIABETES CARE, 2013, 36 (11) : 3517 - 3525
  • [9] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [10] Insulin glargine versus NPH insulin in critically ill medical patients
    Krumenacker, Laura
    Winters, Shauna
    Faircloth, Barbara
    McMillen, James
    Wylie, Doug
    Barlow, Patrick
    Ranganath, Harsha
    Branca, Paul
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
12345